Phase III Clinical Trial to Evaluate the Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine，Recombinant (Hansenula Polymorpha)

Clinical trial NCT05916326 · COMPLETED

Trial details

NCT number: NCT05916326
Sponsor: National Vaccine and Serum Institute, China
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Norovirus Infections Norwalk Gastroenteritis

Start date: 2023-06-30
Primary completion: 2025-07-27
Enrollment: 8000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.